Status:
WITHDRAWN
Accelerated PrEP Access for Black MSM and TW
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
Planned Parenthood Great Plains
Conditions:
HIV/AIDS
Eligibility:
MALE
18-24 years
Phase:
NA
Brief Summary
The investigators will pilot-test an accelerated PrEP initiation approach among young high-risk Black/African American (B/AA) men who have sex with men (MSM) and transgender women (YMSM/TW) at the poi...
Detailed Description
The study team will provide a free 30-day supply of HIV pre-exposure prophylaxis (PrEP) to young Black MSM and TW identified as PrEP-eligible and interested in taking PrEP to reduce their risk of HIV ...
Eligibility Criteria
Inclusion
- ages 18-24;
- assigned male at birth, identify as a man (cisgender), transgender woman, or gender non-conforming or genderqueer;
- identifying as Black, African American, or multiracial with at least one parent identifying as Black or African American;
- not currently taking PrEP or attending a visit to initiate PrEP;
- self-report being HIV-negative;
- reporting one of the following HIV risks in the last 6 months (Hosek, Rudy et al. 2015, Hosek, Rudy et al. 2017): a. condomless anal intercourse with an HIV-infected male partner or a male partner of unknown HIV status; b. anal intercourse with 3 or more male sex partners; c. exchange of money, gifts, shelter, or drugs for anal sex with a male partner; d. sex with a male partner and has had a sexually transmitted infection; e. sexual partner of an HIV-infected male with whom condoms were not consistently used; f. anal intercourse where the condom broke or slipped off
Exclusion
- We are excluding those individuals who were assigned female at birth (female birth certificate) and/or cis-gender women (those assigned female at birth and identify as women) from the all phases of this study as this study is intended to explore the HIV prevention behaviors of B/AA young men who have sex with men and young transgender women (assigned male at birth) as these two groups represent the highest risk groups for HIV infection in the US, yet only a small percentage are aware or currently use PrEP for HIV prevention.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04329442
Start Date
April 1 2020
End Date
July 31 2021
Last Update
May 19 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.